There is also a multidistrict litigation involving transvaginal mesh, in New Jersey, where which Bloomberg News reported on Feb. 28, 2013*** that a jury awarded over $11 million in compensatory and punitive damages to a South Dakota woman.
The South Dakota woman's lawsuit**** over a Johnson & Johnson Gynecare Prolift was the first to go to trial from among 2,100 transvaginal state court mesh lawsuits consolidated in New Jersey.
In the West Virginia litigation involving CR Bard, Bloomberg also reported in its June 26, 2013 posting that in 2004 and 2007 e-mails a Davol executive warned colleagues not to tell Chevron Phillips or other resin makers that the company was using the material in medical devices placed in humans, according to the unsealed court file.
“Suppliers such as Chevron Phillips ‘will likely not be interested in a medical application due to product-liability concerns,’ Roger Darois, the Davol executive, now a Bard vice president, said in a March 2004 e-mail,” Bloomberg reported from the court file. “’It is likely they do not know of our implant application. Please do not mention Davol’s name in any discussion with these manufacturers.’”
Bloomberg reported that “lawyers for thousands of women who blame Bard’s Avaulta line of implants for their injuries said the files show Davol officials knew the resin-based mesh wasn’t proper for human implantation and tried to cover up their use of the material."
Transvaginal mesh side effects were detailed by a Food and Drug Administration warning of “serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse."*****
In the warning issued to health care professionals, the FDA cited recent medical literatur
Copyright©2012 Vocus, Inc.
All rights reserved